NASDAQ:NH NantHealth (NH) Stock Price, News & Analysis $0.0020 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSustainabilityTrends About NantHealth Stock (NASDAQ:NH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NantHealth alerts:Sign Up Key Stats Today's Range$0.0020▼$0.002050-Day Range$0.00▼$0.0352-Week Range$1.24▼$9.75Volume66 shsAverage Volume38,073 shsMarket Capitalization$15,406.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.Read More… Nvidia warning urgent (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. NantHealth Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks7th Percentile Overall ScoreNH MarketRank™: NantHealth scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NantHealth.Read more about NantHealth's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for NH. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNantHealth does not currently pay a dividend.Dividend GrowthNantHealth does not have a long track record of dividend growth. Sustainability and ESG4.3 / 5Environmental Score-0.69 Short InterestThere is no current short interest data available for NH. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for NantHealth this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, NantHealth insiders have not sold or bought any company stock.Percentage Held by Insiders61.30% of the stock of NantHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.50% of the stock of NantHealth is held by institutions.Read more about NantHealth's insider trading history. Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Stock News HeadlinesNantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.comNovember 2 at 2:41 AM | americanbankingnews.comNantHealth (NASDAQ:NH) Coverage Initiated by Analysts at StockNews.comOctober 28, 2024 | americanbankingnews.comMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…November 2, 2024 | Crypto 101 Media (Ad)25 Fun Things to Do in New Hampshire in 2024October 24, 2024 | travel.usnews.comBest High Schools in New HampshireOctober 24, 2024 | usnews.comNew Hampshire boy, 11, trapped between boulders freed after 9-hour ordealSeptember 18, 2024 | nypost.comNantHealth Welcomes Scott Maratea as Chief Revenue Officer to Executive TeamAugust 28, 2024 | tmcnet.comNew Hampshire challenges "unjust" Massachusetts gun laws over impact on residents who cross state linesAugust 23, 2024 | cbsnews.comSee More Headlines NH Stock Analysis - Frequently Asked Questions How have NH shares performed this year? NantHealth's stock was trading at $0.43 at the beginning of the year. Since then, NH shares have decreased by 99.5% and is now trading at $0.0020. View the best growth stocks for 2024 here. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.02. The business earned $14.36 million during the quarter, compared to the consensus estimate of $17.70 million. When did NantHealth IPO? NantHealth (NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Block (SQ) and Gilead Sciences (GILD). Company Calendar Last Earnings11/04/2021Today11/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Data processing & preparation Sub-IndustryN/A Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(855) 949-6268FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-67,780,000.00 Net Margins-94.67% Pretax Margin-95.06% Return on EquityN/A Return on Assets-39.82% Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual Sales$67.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($30.72) per share Price / Book0.00Miscellaneous Outstanding Shares7,703,000Free Float2,981,000Market Cap$15,406.00 OptionableNot Optionable Beta1.82 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report This page (NASDAQ:NH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.